Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)

China flag China · Delayed Price · Currency is CNY
5.00
0.00 (0.00%)
Jun 9, 2026, 3:04 PM CST
Market Cap5.23B -15.8%
Revenue (ttm)1.04B -26.0%
Net Income259.16M -30.2%
EPS0.25 -30.2%
Shares Out 1.05B
PE Ratio20.19
Forward PEn/a
Dividend0.20 (4.00%)
Ex-Dividend DateMay 29, 2026
Volume4,386,513
Open5.10
Previous Close5.00
Day's Range4.96 - 5.10
52-Week Range4.96 - 7.03
Beta0.24
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:300039

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxifying. It also provides liver-protecting products, ... [Read more]

Sector Healthcare
Founded 2000
Employees 1,197
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300039
Full Company Profile

Financial Performance

In 2025, SHE:300039's revenue was 1.15 billion, a decrease of -21.76% compared to the previous year's 1.47 billion. Earnings were 278.58 million, a decrease of -25.83%.

Financial Statements